Grace Therapeutics (GRCE) Receivables (2017 - 2024)
Grace Therapeutics (GRCE) reported Receivables of $418,000 for fiscal Q1 2025 (quarter ended Jun 30, 2024), down 50.1% from $837,000 a year earlier and down 71.1% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Receivables (2017 - 2024) Analysis & Trends
At the end of FY2024 (ended Mar 31, 2024), Grace Therapeutics posted Receivables of $1.44 million, up 80.0% from FY2023.
- Receivables has a five-year compound annual growth rate of 3.9% (FY2019 to FY2024).
- By fiscal year, Receivables came in at $802,000 in FY2023 (+46.4%), $548,000 in FY2022 (unchanged), $548,000 in FY2021 (-4.0%) and $571,000 in FY2020 (-52.1%).
- The fiscal Q1 2025 figure ranks as the lowest quarterly Receivables since fiscal Q3 2022.
- Year over year, Receivables gained in six of the last eight quarters, with growth averaging 40.4%.
- The high point for year-over-year Receivables in five years was fiscal Q3 2023 (growth of 226.9%); the low point was fiscal Q3 2022 (a decline of 61.6%).
- Per Business Quant data, the three fiscal quarters before Q1 2025 came in at $1.44 million (Q4 2024), $987,000 (Q3 2024) and $864,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Grace Therapeutics | 34.37 Mn | -31.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 418,000.00 |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 987,000.00 |
| Sep 30, 2023 | 864,000.00 |
| Jun 30, 2023 | 837,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | 778,000.00 |
| Sep 30, 2022 | 859,000.00 |
| Jun 30, 2022 | 964,000.00 |
| Mar 31, 2022 | 548,000.00 |
| Dec 31, 2021 | 238,000.00 |
| Sep 30, 2021 | 813,000.00 |
| Jun 30, 2021 | 448,000.00 |
| Mar 31, 2021 | 548,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Sep 30, 2020 | 625,000.00 |
| Jun 30, 2020 | 495,000.00 |
| Mar 31, 2020 | 571,000.00 |
| Mar 31, 2019 | 1.18 Mn |
| Mar 31, 2018 | 588,965.65 |
API Access
Grace Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();